• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Anti-inflammatory "switch" could treat diabetes, MS and aging itself

sirt1 sirt2 sirt3 sirt4 sirt5 sirt6 sirt7 nlrp3 caspase 1 inflammasome

  • Please log in to reply
No replies to this topic

#1 Engadin

  • Guest
  • 198 posts
  • 580
  • Location:Madrid
  • NO

Posted 07 February 2020 - 08:36 PM


.

 

 

 

 

S O U R C E :   NewAtlas

 

P A Y W A L L E D   P R I M A L   S O U R C E :   Cell Metabolism (An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance)

 

 

 

 

 

nlrp3.png

 

A molecular model of the NLRP3 inflammasome.

 

 

 

Inflammation is the body’s way of fighting off threats, but if it gets out of hand it can lead to painful chronic inflammation, and even contribute to diseases like Alzheimer’s and diabetes. Now, researchers at UC Berkeley have identified a molecular “switch” in mice that could effectively turn off that reaction, potentially reversing these conditions and possibly even aging itself.

 

At the heart of the study is what’s known as the NLRP3 inflammasome. This group of immune proteins keeps a watchful eye out for infections and other invaders to the body, and if it detects something it launches an inflammatory response to fight it off.
 
Normally this is an important function of the immune system, but sometimes the body stays in this heightened state for too long, causing chronic inflammation. This can not only cause pain and discomfort, but can lead to other chronic conditions like multiple sclerosis, cancer, diabetes, Alzheimer’s and Parkinson’s.
 
But on the new study, the researchers found a way to essentially switch off the NLRP3 inflammasome. This is done through a process called deacetylation, where a fragment of molecular matter is removed.
 
“This acetylation can serve as a switch,” says Danica Chen, senior author of the study. “So, when it is acetylated, this inflammasome is on. When it is deacetylated, the inflammasome is off.”
 
Specifically, the team found that a protein called SIRT2 acted as the switch. They engineered mice that were unable to produce SIRT2, and over two years compared their health to a control group. They found that the test animals showed more signs of inflammation, and had higher insulin resistance – a problem that arises during type 2 diabetes.
 
In other tests, the team studied two groups of older mice that had had their immune systems effectively “rebooted.” The animals’ immune systems were reconstituted to have either the acetylated or deacetylated versions of the NLRP3 inflammasome. The differences were then compared after six weeks, and the researchers found that the deacetylated mice had better insulin resistance than the control group.
 
 
fx1.jpg
 
 
 
 
.../...
 
 
 
 
 
 
 
 
.

Edited by Engadin, 07 February 2020 - 08:38 PM.






Also tagged with one or more of these keywords: sirt1, sirt2, sirt3, sirt4, sirt5, sirt6, sirt7, nlrp3, caspase 1, inflammasome

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users